Literature DB >> 24966966

Diagnostic utility of WT-1 cytoplasmic stain in variety of vascular lesions.

Sarah K Galfione1, Jae Y Ro1, Alberto G Ayala1, Yimin Ge1.   

Abstract

Vascular lesions are commonly encountered in routine pathologic practice and often pose diagnostic challenges owing to their morphologic diversity. Although WT-1 expression was reported in some vascular tumors, little is known about its staining patterns in a spectrum of vascular lesions from various locations. We examined WT-1 immunostain in 95 cases of vascular lesions including angiosarcomas (AS, 19 cases), hemangioendotheliomas (HE, 5), Kaposi's sarcomas (KS, 4), cavernous hemangiomas (CVH, 12), capillary hemangiomas (CPH, 7), pyogenic granulomas (PG, 4), lymphangiomas (LA, 4), hemangiopericytomas (HP, 5), glomus tumors (GT, 8), vascular malformation (VM, 13) and granulation tissue (GRT, 14). Strong WT-1 cytoplasmic stain was invariably observed in all cases of malignant and borderline vascular tumors including AS (19/19), KS (4/4) and HE (5/5). WT-1 was also consistently expressed in CPH (7/7), PG (4/4), and GRT (14/14), while it became weaker in VM (10/13) and often negative in CVH (2/12) and LA (0/4). WT1 stain was not demonstrated in HP (0/5) and rarely in GT (2/8). We conclude that consistent and diffuse WT-1 cytoplasmic stain in AS, HE and KS can be useful in distinguishing these tumors from poorly differentiated tumors with mimicking features. On the other hand, reliable WT-1 stain in CPH, PG and GRT may help in differential diagnosis with non-endothelial vascular tumors such as GT and HP. Recognizing the WT-1 cytoplasmic stain in a broad spectrum of benign and neoplastic tissues is critical in formulating appropriate immunohistochemical panels and avoiding misinterpretation of results.

Entities:  

Keywords:  WT-1; angiogenesis; endothelial proliferation; immunohistochemistry; vascular tumor

Mesh:

Substances:

Year:  2014        PMID: 24966966      PMCID: PMC4069888     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  25 in total

1.  Wilms' tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation.

Authors:  D M Loeb; E Evron; C B Patel; P M Sharma; B Niranjan; L Buluwela; S A Weitzman; D Korz; S Sukumar
Journal:  Cancer Res       Date:  2001-02-01       Impact factor: 12.701

2.  An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor.

Authors:  D A Haber; A J Buckler; T Glaser; K M Call; J Pelletier; R L Sohn; E C Douglass; D E Housman
Journal:  Cell       Date:  1990-06-29       Impact factor: 41.582

3.  The Wilms' tumor suppressor Wt1 is expressed in the coronary vasculature after myocardial infarction.

Authors:  Kay-Dietrich Wagner; Nicole Wagner; Anja Bondke; Benno Nafz; Bert Flemming; Heinz Theres; Holger Scholz
Journal:  FASEB J       Date:  2002-05-08       Impact factor: 5.191

4.  Nestin expression by newly formed human blood vessels.

Authors:  J Mokrý; D Cízková; S Filip; J Ehrmann; J Osterreicher; Z Kolár; D English
Journal:  Stem Cells Dev       Date:  2004-12       Impact factor: 3.272

5.  Overexpression of the Wilms' tumor gene W T1 in primary astrocytic tumors.

Authors:  Yusuke Oji; Tsuyoshi Suzuki; Yoko Nakano; Motohiko Maruno; Shin-Ichi Nakatsuka; Tanyarat Jomgeow; Sakie Abeno; Naoya Tatsumi; Asumi Yokota; Sayaka Aoyagi; Tsutomu Nakazawa; Ken Ito; Keisuke Kanato; Toshiaki Shirakata; Sumiyuki Nishida; Naoki Hosen; Manabu Kawakami; Akihiro Tsuboi; Yoshihiro Oka; Katsuyuki Aozasa; Toshiki Yoshimine; Haruo Sugiyama
Journal:  Cancer Sci       Date:  2004-10       Impact factor: 6.716

Review 6.  The Wilms' tumor 1 gene: oncogene or tumor suppressor gene?

Authors:  A L Menke; A J van der Eb; A G Jochemsen
Journal:  Int Rev Cytol       Date:  1998

7.  WT1 is a tumor-associated antigen in colon cancer that can be recognized by in vitro stimulated cytotoxic T cells.

Authors:  Robert Koesters; Michael Linnebacher; Johannes F Coy; Anja Germann; Yvette Schwitalle; Peter Findeisen; Magnus von Knebel Doeberitz
Journal:  Int J Cancer       Date:  2004-04-10       Impact factor: 7.396

8.  Overexpression of the Wilms' tumor gene WT1 in human bone and soft-tissue sarcomas.

Authors:  Takafumi Ueda; Yusuke Oji; Norifumi Naka; Yoko Nakano; Eigo Takahashi; Satoko Koga; Momotaro Asada; Ai Ikeba; Shin-ichi Nakatsuka; Sakie Abeno; Naoki Hosen; Yasuhiko Tomita; Katsuyuki Aozasa; Noriyuki Tamai; Akira Myoui; Hideki Yoshikawa; Haruo Sugiyama
Journal:  Cancer Sci       Date:  2003-03       Impact factor: 6.716

9.  An immunohistochemical study of verrucous hemangiomas.

Authors:  Felicidade Trindade; Antonio Torrelo; Luis Requena; Oscar Tellechea; Jesus Del Pozo; Felipe Sacristán; Altea Esteve-Martínez; Blanca de Unamuno; Víctor Alegre de Miquel; Isabel Colmenero
Journal:  J Cutan Pathol       Date:  2013-05       Impact factor: 1.587

10.  Upregulation of Wilms' tumor gene 1 (WT1) in desmoid tumors.

Authors:  Saeid Amini Nik; Peter Hohenstein; Ali Jadidizadeh; Kim Van Dam; Adriana Bastidas; Rachel L Berry; Charles E Patek; Bernadette Van der Schueren; Jean-Jacques Cassiman; Sabine Tejpar
Journal:  Int J Cancer       Date:  2005-03-20       Impact factor: 7.396

View more
  1 in total

1.  Immunohistochemical Expression of Wt-1 Helps to Differentiate Cutaneous Vascular Tumors from Vascular Malformations.

Authors:  Manisha Choudhary; Ira Sharma; Manveen Kaur; Varsha Dalal; Avninder Singh
Journal:  Indian Dermatol Online J       Date:  2017 Jul-Aug
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.